• Profile
Close

Anemia and neutrophil-to-lymphocyte ratio in laryngeal cancer treated with induction chemotherapy

The Laryngoscope Apr 26, 2019

Gorphe P, et al. - Researchers used a retrospective single-center case series to determine how the response to induction chemotherapy (IC) and survival outcomes in laryngeal cancer patients treated with a preservation protocol are impacted by neutrophil-to-lymphocyte ratio (NLR) and anemia. They analyzed 68 patients. A high NLR ratio and anemia before IC were linked to shorter survival in laryngeal cancer patients treated with a preservation protocol, independent of the response to chemotherapy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay